These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 449958)

  • 1. Vasodilator drugs for peripheral vascular disease.
    Cook CD
    N Engl J Med; 1979 Jul; 301(3):159. PubMed ID: 449958
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasodilator drugs for peripheral vascular disease.
    Coffman JD
    N Engl J Med; 1979 Jul; 301(3):159-60. PubMed ID: 109756
    [No Abstract]   [Full Text] [Related]  

  • 3. Peripheral vasodilator drugs.
    Br Med J; 1969 Jul; 3(5661):38-40. PubMed ID: 5787285
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vasodilation caused by inhibition of calcium ions as a factor of increasing oxygen transport in peripheral vascular diseases].
    Pola P; Savi L; Dal Lago A; Zucchiatti V
    Clin Ter; 1977 Jun; 81(5):417-31. PubMed ID: 884936
    [No Abstract]   [Full Text] [Related]  

  • 5. Raynaud's disease treated with griseofulvin.
    Creery RD; Voyce MA; Preece AW; Evason AR
    Arch Dis Child; 1968 Jun; 43(229):344-6. PubMed ID: 5652712
    [No Abstract]   [Full Text] [Related]  

  • 6. [Griseofulvin administered for an indeterminate time in the therapy of systemic scleroderma and Raynaud's syndrome].
    Giordano M; Capelli L; Ara M; Tirri G
    Reumatismo; 1971; 23(2):82-92. PubMed ID: 5146109
    [No Abstract]   [Full Text] [Related]  

  • 7. [Symptomatic treatment of Raynaud's phenomenon: reserpine, alpha-methyldopa, griseofulvin, guanethidine].
    Zicot M
    Rev Med Liege; 1980 Oct; 35(19):652-4. PubMed ID: 6161403
    [No Abstract]   [Full Text] [Related]  

  • 8. Griseofulvin in Raynaud's phenomenon.
    Naidoo P
    Lancet; 1971 Nov; 2(7733):1090. PubMed ID: 4106930
    [No Abstract]   [Full Text] [Related]  

  • 9. Griseofulvin in Raynaud's disease.
    Hasker WE
    Lancet; 1970 Nov; 2(7683):1136. PubMed ID: 4097937
    [No Abstract]   [Full Text] [Related]  

  • 10. Griseofulvin in Raynaud's phenomenon.
    Allen BR
    Lancet; 1971 Oct; 2(7729):840-1. PubMed ID: 4106870
    [No Abstract]   [Full Text] [Related]  

  • 11. Vasodilator drugs for peripheral vascular disease.
    Beaucher WN
    N Engl J Med; 1979 Jul; 301(3):159. PubMed ID: 109755
    [No Abstract]   [Full Text] [Related]  

  • 12. Vasodilator drugs and peripheral vascular disease.
    Drug Ther Bull; 1972 Nov; 10(23):91-2. PubMed ID: 4144248
    [No Abstract]   [Full Text] [Related]  

  • 13. Skin temperature changes in Raynaud's disease after griseofulvin.
    Charles CR; Carmick ES
    Arch Dermatol; 1970 Mar; 101(3):331-6. PubMed ID: 5414890
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study on digital arterial reactivity in a case of Raynaud's disease].
    Lipparini R; Semeraro S; Palmieri F
    Arch Patol Clin Med; 1970 Aug; 46(3):233-50. PubMed ID: 5491567
    [No Abstract]   [Full Text] [Related]  

  • 15. [Raynaud's phenomenon: diagnostic and therapeutic aspects].
    Soro P; Occhioni G; Spissu M; Trignano M; Dettori G; Bacciu PP; Biglioli P
    Chir Ital; 1981 Jun; 33(3):647-60. PubMed ID: 7307205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe vasospasm following ergot administration.
    Robb LG
    West J Med; 1975 Sep; 123(3):231-5. PubMed ID: 1162985
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new peripheral vasodilator prostaglandin E1 in atherosclerosis of lower limb vessels and Raynaud disease].
    Kirichenko AA; Novichkova IuN; Zubkova LV; Ter-Gevondian NM; Nenakhova TV
    Klin Med (Mosk); 1991 Nov; 69(11):40-3. PubMed ID: 1808404
    [No Abstract]   [Full Text] [Related]  

  • 18. [Differential diagnosis of peripheral vasomotor disorders of vibration and nonvibration origin].
    Petrenko BE; Vydrin ML
    Gig Tr Prof Zabol; 1981 Jul; (7):8-11. PubMed ID: 6269964
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preliminary results of a clinical and instrumental study of cerebral and peripheral artery circulation with a new phytotherapeutic agent (Ginko biloba)].
    Saponaro A; Gambelli G; Cosentino F
    Minerva Med; 1971 Dec; 62(97):4838-49. PubMed ID: 5131191
    [No Abstract]   [Full Text] [Related]  

  • 20. The action of tetranicotinoylfructose in peripheral vascular disease.
    Andrews G; Judge TG; Walkey F
    Practitioner; 1973 Jul; 211(261):83-5. PubMed ID: 4580277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.